Form 4: Bio-Rad Laboratories Director Acquires Shares Through Vesting of Restricted Stock Units

Director Arnold A. Pinkston acquired 308 shares of Bio-Rad Laboratories Class A common stock through the vesting of restricted stock units on April 22, 2025.

Summary

• On April 22, 2025, Arnold A. Pinkston, a director of Bio-Rad Laboratories, acquired 308 shares of Class A common stock.
• This acquisition resulted from the vesting of restricted stock units (RSUs).
• Pinkston also holds 407 restricted stock units that will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders.
• Additionally, Pinkston previously held 308 restricted stock units granted on September 6, 2024, which also vested on April 22, 2025.
• Following these transactions, Pinkston directly owns 308 shares of Bio-Rad Class A common stock and 407 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing a routine transaction. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Future Outlook

The remaining restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders.

Industry Context

This is a routine disclosure of insider transactions, common for directors and officers of publicly traded companies.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it involves the vesting of previously granted equity compensation.

Key Dates

Keywords

Bio-Rad Laboratories, Director, Arnold A. Pinkston, Class A Common Stock, Restricted Stock Units, Vesting, Form 4, Securities